Compile Data Set for Download or QSAR
Report error Found 46 Enz. Inhib. hit(s) with all data for entry = 11792
TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648384BDBM648384(US11352350, Compound I-6)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648385BDBM648385(US11352350, Compound I-7)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648386BDBM648386(US11352350, Compound I-8)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648387BDBM648387(US11352350, Compound I-9)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648380BDBM648380(US11352350, Compound I-2)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648381BDBM648381(US11352350, Compound I-3)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648392BDBM648392(US11352350, Compound I-17)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648393BDBM648393(US11352350, Compound I-18)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648394BDBM648394(US11352350, Compound I-27)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648388BDBM648388(US11352350, Compound I-10)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648389BDBM648389(US11352350, Compound I-11)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648391BDBM648391(US11352350, Compound I-16)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648416BDBM648416(US11352350, Compound I-59)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648418BDBM648418(US11352350, Compound I-62)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648419BDBM648419(US11352350, Compound I-65)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648414BDBM648414(US11352350, Compound I-48)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648415BDBM648415(US11352350, Compound I-58)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648401BDBM648401(US11352350, Compound I-34)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648402BDBM648402(US11352350, Compound I-35)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648403BDBM648403(US11352350, Compound I-36)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648395BDBM648395(US11352350, Compound I-30 | US11352350, Compound I...)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648399BDBM648399(US11352350, Compound I-32)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648408BDBM648408(US11352350, Compound I-41)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648409BDBM648409(US11352350, Compound I-42)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648411BDBM648411(US11352350, Compound I-45)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648404BDBM648404(US11352350, Compound I-37)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648405BDBM648405(US11352350, Compound I-38)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648407BDBM648407(US11352350, Compound I-40)
Affinity DataIC50: 50nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648417BDBM648417(US11352350, Compound I-61)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648398BDBM648398(US11352350, Compound I-31)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648410BDBM648410(US11352350, Compound I-43)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648395BDBM648395(US11352350, Compound I-30 | US11352350, Compound I...)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648420BDBM648420(US11352350, Compound I-67)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648421BDBM648421(US11352350, Compound I-75)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648422BDBM648422(US11352350, Compound I-76)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648406BDBM648406(US11352350, Compound I-39)
Affinity DataIC50: 75nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648378BDBM648378(US11352350, Compound I-1)
Affinity DataIC50: 300nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648383BDBM648383(US11352350, Compound I-5)
Affinity DataIC50: 300nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648424BDBM648424(US11352350, Compound I-92)
Affinity DataIC50: 300nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648425BDBM648425(US11352350, Compound I-94)
Affinity DataIC50: 300nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648400BDBM648400(US11352350, Compound I-33)
Affinity DataIC50: 750nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648412BDBM648412(US11352350, Compound I-46)
Affinity DataIC50: 750nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648396BDBM648396(US11352350, Compound I-29)
Affinity DataIC50: 750nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648413BDBM648413(US11352350, Compound I-47)
Affinity DataIC50: 750nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648390BDBM648390(US11352350, Compound I-12)
Affinity DataIC50: 750nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Kymera Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648423BDBM648423(US11352350, Compound I-81)
Affinity DataIC50: 1.00E+3nMAssay Description:Whole blood was collected in heparinized tubes and plated on the same day as draw (day 0). Whole blood was aliquoted into deep well plates. Compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2024
Entry Details
US Patent